Journal of Pharmaceutical and Biomedical Sciences

In vitro Antifungal Activity of Pluronic-based Thermo-Sensitive Itraconazole Gels for Vaginal Administration

Ye Qiumian, Ye Xiaocui, Luo Rui, Ou Jinlai, Xu Zhenxia, Zhao Wen, Li Sha

Abstract


Vulvovaginal candidiasis (VVC) is a common genital disease disturbing women. ITZ is widely used for the treatment of VVC by oral administration in clinic. Due to its irregular absorption and systematic side effects, local administration of ITZ may be a preferred alternative for VVC treatment. The aim of this study was to investigate the in vitro antifungal activity of pluronic-based thermo-sensitive gels (TSG) of itraconazole (ITZ) for vaginal administration. 3-(4,5-2-yl)-2,5-diphenyltetrazolium bromide method was used to evaluate the antifungal activity of the ITZ-TSG against major microorganisms inducing vulvovaginal candidosis. The gelation temperature of ITZ-TSG was 25 and 35°C before and after the dilution of simulated vaginal fluid. Compared with ITZ, ITZ-TSG demonstrated effective antifungal activity and the gel vehicle showed no action. It suggested that ITZ-TSG may be a good candidate for vulvovaginal candidosis treatment.

Keywords


itraconazole, thermosentitive gels, antifungal activity in vitro, vaginal administration

Full Text:

References


Keller KA. Therapeutic review. J Exotic Pet Med. 2011;20(2):156–60.

Francois M, Snoeckx E, Putteman P, Wouters F, De Proost E, Delaet U, et al. A mucoadhesive, cyclodextrin-based vaginal cream formulation of itraconazole. AAPS PharmSci. 2003;5(1):50–54.

Xiao-cui YE, Jin-lai OU, Bao-xian H, Cui-juan F, Sha L. Preparation and characteristics of itraconazole vaginal thermosensitive in situ gels. J Cent South Pharm. 2014;12(6):551–556.

Zhang HH, Luo QH, Yang ZJ, Pan WS, Nie SF. Novel ophthalmic timolol meleate liposomal-hydrogel and its improved local glaucomatous therapeutic effect in vivo. Drug Deliv. 2011;18(7): 502–10.

das Neves J. Vaginal delivery of biopharmaceuticals. In: das Neves J, Sarmento B (eds). Mucosal delivery of biopharmaceuticals: biology, challenges and strategies, Springer: New York; 2014. pp. 261–80.

Yi Y, Yoon HJ, Kim BO, Shim M, Kim SO, Hwang SJ, et al. A mixed polymeric micellar formulation of itraconazole: characteristics, toxicity and pharmacokinetics. J Control Release. 2007;117(1):59–67.

Odds FC. Itraconazole: a new oral antifungal agent with a very broad spectrum of activity in superficial and systemic mycoses. J Dermatol Sci. 1993;5(2):65–72.

Sobel JD, Faro S, Force RW. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol. 1998;178(2):203–211.

Sinem Y, Seda R, Zeynep AY, Esra B. A new in-situ gel formulation of itraconazole for vaginal administration. Pharmacol Pharm. 2012;3:417–426.

Gupta A, Bluhm R. Itraconazole (Sporanox®) for vulvovaginal candidiasis. Skin Ther lett. 2001;7:1–3.

Tian F, Wang YZ, Yang K, Wen CL, Cheng QQ, LI WH, et al. Rheological characteristics of nifeviroc vaginal thermosensitive in situ gels. Chin J New Drugs. 2013;22(3):345–350.

Wang CW, Tang X, Wang XM, Tian XL, LI Z. Preparation of temperature-sensitive nonoxynol-9 sustained-release gel for vagina. Chin J New Drugs. 2006;15(4):281–284.

Puxiang C, Shangrong F. Development in classification, mycology and treatment of vulvovaginal candidiasis. Foreign Med Sci. 2005;16(4):235–237.

Meletiadis J, Meis JF, Mouton JW, Donnelly JP, Verweij PE. Comparison of NCCLS and 3-(4,5-dimethyl-2-thiazyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) methods of in vitro susceptibility testing of filamentous fungi and development of a new simplified method. J Clin Microbiol. 2000;38(8):2949–54.

Genyan L, Wangsheng Z. In vitro drug sensitivity test of pathogenic fungi. J Clin Labor. 2011;06:406–409.

Yangjun S. In vitro interaction research of tetrandrine combined with azole antifungal agents. Jinan Univ. 2013.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 Journal of Pharmaceutical and Biomedical Sciences

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.